Who is actually holding the laser: a three question supervision script

You book a consultation with a named physician. You meet them for eleven minutes. On the day of treatment, somebody else does the procedure. This is not a bait and switch, it is the ordinary operating model of a large part of the aesthetics industry, and in most of the United States it is lawful.

What is not ordinary, and what varies far more than patients realise, is the answer to a narrower question. When that other person is holding the device, where is the physician. In the room. In the building. Reachable by telephone. Or a name on a contract who has never been to the premises.

The original element in this piece is a side by side account of the three fundamentally different regulatory models American states use for delegated laser treatment, showing exactly where they contradict each other, followed by a three question script for finding out which one you are standing in. Comparisons of state law exist in trade and legal writing. What does not exist for patients is the version that explains why the same treatment can be legal under three incompatible sets of rules, and what to do with that.

Why this is not an abstract concern. The injury and litigation pattern has been examined directly. Analysis of cutaneous laser surgery litigation found a rising share of cases involving nonphysician operators, and found that the proportion of lawsuits involving nonphysician operators grew substantially over the period studied (JAMA Dermatol 2014). A later update covering 2012 to 2020 examined the causes of injury and legal action across the same field (Dermatol Surg 2022), and a companion analysis catalogued the common injury patterns themselves (JAMA Dermatol 2013).

The point is not that a nonphysician operator is unsafe. Many are highly experienced and treat more patients in a month than a supervising physician has treated in a career. The point is that the framework around them differs, and the framework is what determines who is available in the ninety seconds after something goes wrong.

Model one, direct or on site supervision. Some jurisdictions require the supervising physician to be physically present on the premises while a delegated laser or energy device treatment is performed, and in the narrowest versions require them to be immediately available in a way that means the same floor rather than the same postcode. Under this model the answer to your question is simple and checkable. Somebody is there.

Model two, indirect or general supervision. Other jurisdictions require only that the supervising physician be reachable, typically by telephone or electronic means, and available to attend within a reasonable time. The physician may be at another clinic, at home, or in another city. The delegating physician still carries responsibility, and in most versions must have established the treatment plan and conducted an initial assessment, but they are not present.

Model three, device or practitioner licensure outside medicine. A third group of states handles this differently again, licensing the use of certain devices under a separate scheme, or placing some treatments partially under cosmetology or electrology boards rather than the medical board. Under these frameworks the question of physician supervision may be partly beside the point, because the operator holds their own authorisation for the specific device class.

Where the three models directly contradict each other. The contradiction is not a matter of degree, it is a matter of category, and there are three specific points of collision.

The first is whether the physician must be present. Model one says yes and means it physically. Model two says no and means telephone contact is sufficient. Both describe themselves as supervision, and a clinic operating under model two can truthfully tell you the treatment is physician supervised while the physician is a hundred miles away.

The second is who is permitted to hold the device. Some frameworks restrict delegation to licensed medical personnel, meaning a physician assistant, nurse practitioner or registered nurse. Others permit delegation more broadly, including to unlicensed personnel trained on the device. A treatment performed entirely lawfully in one state may not be lawful across a state line, performed by the same person on the same machine.

The third is whether the physician must personally see you first. Some frameworks require a physician performed initial assessment and a written treatment plan before delegation. Others allow the assessment itself to be delegated. This is the one patients notice least and it is arguably the one that matters most, because it determines whether anyone with prescribing level training ever evaluated whether the treatment is appropriate for your skin.

The three questions. Ask them at booking, not on the day, because on the day you are already gowned and it is much harder to leave.

First: who will be performing my treatment, and what is their licence or certification. You want a role and a credential, not a first name. A confident, specific answer is a good sign in itself.

Second: will a physician or licensed prescriber be on the premises while my treatment is performed, and if not, what is the arrangement for reaching them. This is the question that distinguishes model one from model two, and it is the question clinics answer least often in their marketing.

Third: who set my treatment settings, and what happens if I have an adverse reaction during or immediately after. You are asking two things at once. Whether the parameters were chosen by someone qualified to choose them for your particular skin, and whether there is a written protocol and a person responsible for executing it.

How to interpret the answers. A clinic that answers all three crisply is a clinic that has thought about it. A clinic that answers the first two and stumbles on the third has staff but no protocol. A clinic that becomes evasive at the second question is usually operating under model two and would rather you did not think about it, which is worth knowing but is not by itself disqualifying.

The genuinely bad answer is a clinic that cannot name the supervising clinician at all, or that describes supervision in terms of a company rather than a person. That is the situation in which nobody is accountable, and it is the pattern that recurs in the litigation analyses.

What the studies do not tell you. No published work has compared complication rates between the three supervision models directly. Nobody has taken matched patients treated under on site supervision versus telephone supervision and counted burns, scars or pigmentary complications. What exists is litigation data, which reflects both the underlying rate of injury and the propensity to sue, and those are not the same thing. The models differ in what protection they offer in principle. Whether that translates into different outcomes in practice is an open question and should be described as one.

Regulation also changes. Any specific statement about what your state requires today may be out of date by the time it matters, which is a further reason to ask the clinic directly rather than to rely on a summary.

Why to bother. Because the answer changes with the treatment. For a low energy treatment on light skin the stakes are modest. For an ablative device, for anything on darker skin where the margin for error in device settings is narrower, and for anything involving an injectable that could occlude a vessel, the difference between a prescriber in the building and a prescriber on a phone is the entire difference. It belongs alongside the other homework in what to ask before a non surgical treatment, it is why FDA cleared does not mean what people assume, and it matters most in exactly the population where device settings are least forgiving, discussed in treatments and darker skin tones.